Version 2.0 of the Draft CRI Guidelines 2025 introduces updated examination procedures for AI, blockchain, and quantum-based inventions, and includes an extensive annexure of examples clarifying Section 3(k) exclusions.
Read more about Indian Patent Office Issues Draft CRI Guidelines 2025 – Version 2.0: Key Additions and ChangesAuthor: Gaurav Mishra
Shindengen’s Patent Application remanded for fresh consideration for lack of reasoned order
The Calcutta High Court remanded Shindengen Electric’s 2015 patent application after finding that the rejection order lacked proper reasoning. The decision emphasised the need for administrative transparency and importance of importance of judicial reasoning.
Read more about Shindengen’s Patent Application remanded for fresh consideration for lack of reasoned orderBusiness Potential of Industrial Design in India – An unexplored goldmine
Though often overlooked in India, industrial design offers powerful commercial advantages. This blog explores its role in product differentiation, IP protection, and global competitiveness. With increasing design filings and cost-effective registration, it’s time Indian businesses tapped into this underused IP tool.
Read more about Business Potential of Industrial Design in India – An unexplored goldmineWhy Are Patents Expensive? A guide to patent costs and value
This post breaks down why patents are expensive, detailing costs across various stages, from drafting to international filings. It also explains how thoughtful investment in patent services ensures stronger protection and long-term value for innovators and businesses.
Read more about Why Are Patents Expensive? A guide to patent costs and valueAkebia’s patent for Anemia therapy gets fresh blood from Court
In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to compositions, as long as they’re disclosed in the original application. The case underscores the significance of well-documented specifications in pharmaceutical patents.
Read more about Akebia’s patent for Anemia therapy gets fresh blood from CourtPatent Claim Amendments – Court’s observation of amendments to systems, methods and use claims
The Calcutta High Court remanded a patent application back to the Controller of Patents, citing infrimities in evaluating claim amendments. The Court stressed that mere change in claim types—method to system—without analyzing technical substance cannot justify rejection under Section 59 of the Indian Patents Act.
Read more about Patent Claim Amendments – Court’s observation of amendments to systems, methods and use claimsWhat Have You Been Smoking? Personal bias has no place in Tobacco patent evaluation
The Calcutta High Court has criticised the arbitrary rejection of a tobacco syrup patent by the Indian patent office, urging objective analysis over personal bias. It held that Section 3(b) must not be misused to deny legitimate inventions without proper legal scrutiny and evidence.
Read more about What Have You Been Smoking? Personal bias has no place in Tobacco patent evaluation